| congestive heart failure |
|
Commonly prescribed medications for control of hypertension and congestive heart failure are inhibitors of the RAAS, including angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin II (A-II) receptor antagonists.
|
| |
|
Complex clinical-laboratory investigation of children with congestive heart failure developed on the basis of dilated cardiomyopathy and hypertrophic cardiomyopathy has been carried out.
|
| |
|
The majority of the anomalies are of benign prognosis, but others can be associated with cardiac symptoms and syndromes (angina, dyspnea, syncope, congestive heart failure, myocardial infarction and sudden death).
|
| |
|
Congestive heart failure (CHF) has emerged as a major worldwide epidemic and its main causes seem to be the aging of the population and the survival of patients with post-myocardial infarction.
|
| |
|
Thyrotoxicosis is not only able to aggravate preexisting cardiac disease but can also by itself lead to atrial fibrillation, cardiomegaly or congestive heart failure.
|
| |
|
This case report deals with severe congestive heart failure, dilatation of the left ventricle, and tachyarrhythmia without preexisting heart disease in a patient with Graves disease.
|
| |
|
The special implications of cardiavascular pharmacotherapy, especially the risk of early β-blocker therapy in patients suffering from thyrotoxicosis with severe congestive heart failure are emphasized.
|
| |
|
Additionally, the MAPPET registry outlines risk factors for increased in-hospital mortality of acute pulmonary embolism, i.e., syncope, hypotension, history of congestive heart failure, and chronic pulmonary disease.
|
| |
|
Respiratory muscle/circulation interaction in congestive heart failure
|
| |
|
In patients with congestive heart failure digoxin or amiodarone can be useful.
|
| |
|
Recently published data confirm the value of TWA assessment with respect to identification of patients with congestive heart failure at high risk of malignant ventricular tachyarrhythmias.
|
| |
|
Outpatient intermittent dobutamine therapy in congestive heart failure
|
| |
|
We describe the clinical outcome of 40 pts with severe congestive heart failure (CHF) treated with outpatient dobutamine (D) Therapy.
|
| |
|
Amiodarone and implantable cardioverter-defibrillators in congestive heart failure
|
| |
|
It has also been linked with the progression of aortic aneurysms and with left ventricular dilatation in congestive heart failure in patients with ischemic and non-ischemic cardiomyopathy.
|
| |
|
In contrast to the often debated NYHA classification, the determination of peak oxygen uptake (peak VO2) by cardiopulmonary exercise testing allows an objective assessment of the exercise capacity of patients with congestive heart failure (CHF).
|
| |
|
Newborn babies and infants with paroxysmal atrioventricular reentrant tachycardias usually present with signs of congestive heart failure due to rapid heart rate.
|
| |
|
Physical examination showed signs of biventricular congestive heart failure and dysmorphia of the face.
|
| |
|
If the results translate to patients, PS may be very beneficial in the treatment of AF in patients with congestive heart failure.
|
| |
|
This can be demonstrated in patients with survived myocardial infarction, dilative cardiomyopathy and congestive heart failure.
|
| |